MARKET INTRODUCTION
Leukapheresis is the procedure of separating white blood cells from the blood sample. The Leukapheresis is performed to reduce the high number of white blood cell count in order to transfer them back to the patient or use it for research purpose. Moreover, during the process of chemotherapy, white blood cells are removed to protect them from damage caused due to high dose chemotherapy drugs and then are transferred back into patient's body.
MARKET DYNAMICS
The Leukapheresis market is expected to grow in coming years owing to factors such as increase in number of blood donation, rise in incidences of leukemia cancer, increase in demand of leukopaks in cell based therapies and rise in prevalence of trauma cases. On the other hand growing policies on reimbursements and increase in number of complex surgeries are expected to likely offer opportunities in market growth.
MARKET SCOPE
The "Global Leukapheresis Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global medical device market trend analysis. The report aims to provide an overview of Leukapheresis market with detailed market segmentation by product type, application, end user and geography. The global Leukapheresis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Leukapheresis market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Leukapheresis market is segmented on the basis of product type, application and end user. Based on product type, the market is segmented as Leukapheresis devices, Leukapheresis disposables. On the basis of application, the global Leukapheresis market is segmented into research applications and therapeutic applications. Based on end user, the market is segmented as blood component providers and blood centers, academic and research institutes, pharmaceutical and biotechnology companies and hospitals and transfusion centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Leukapheresis market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Leukapheresis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Leukapheresis market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Leukapheresis market in these regions.
MARKET PLAYERS
The reports cover key developments in the Leukapheresis market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Leukapheresis market are anticipated to lucrative growth opportunities in the future with the rising demand for Leukapheresis in the global market. Below mentioned is the list of few companies engaged in the Leukapheresis market.
The report also includes the profiles of key Leukapheresis market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Janssen Global Services, LLC
- Grifols, S.A
- NIHON KOHDEN CORPORATION.
- Siemens Healthcare Private Limited
- BioRad Laboratories Inc.
- F. Hoffmann-La Roche Ltd
- Abcam plc.
- BioLegend, Inc.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. PublisherS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
  1.3.1 Leukapheresis Market - By Product Type
  1.3.2 Leukapheresis Market - By Application
  1.3.3 Leukapheresis Market - By End User
  1.3.4 Leukapheresis Market - By Region
  1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LEUKAPHERESIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
  4.2.1 North America - Pest Analysis
  4.2.2 Europe - Pest Analysis
  4.2.3 Asia-Pacific - Pest Analysis
  4.2.4 Middle East and Africa - Pest Analysis
  4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LEUKAPHERESIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LEUKAPHERESIS MARKET - GLOBAL MARKET ANALYSIS
6.1. LEUKAPHERESIS - GLOBAL MARKET OVERVIEW
6.2. LEUKAPHERESIS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. LEUKAPHERESIS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. LEUKAPHERESIS DEVICES
  7.3.1. Overview
  7.3.2. Leukapheresis Devices Market Forecast and Analysis
  7.3.3. Apheresis Devices Market
  7.3.3.1. Overview
  7.3.3.2. Apheresis Devices Market Forecast and Analysis
  7.3.4. Leukapheresis Columns and Cell Separators Market
  7.3.4.1. Overview
  7.3.4.2. Leukapheresis Columns and Cell Separators Market Forecast and Analysis
  7.3.5. Leukoreduction Filters Market
  7.3.5.1. Overview
  7.3.5.2. Leukoreduction Filters Market Forecast and Analysis
7.4. LEUKAPHERESIS DISPOSABLES
  7.4.1. Overview
  7.4.2. Leukapheresis Disposables Market Forecast and Analysis
8. LEUKAPHERESIS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. RESEARCH APPLICATIONS
  8.3.1. Overview
  8.3.2. Research Applications Market Forecast and Analysis
8.4. THERAPEUTIC APPLICATIONS
  8.4.1. Overview
  8.4.2. Therapeutic Applications Market Forecast and Analysis
9. LEUKAPHERESIS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. BLOOD COMPONENT PROVIDERS AND BLOOD CENTERS
  9.3.1. Overview
  9.3.2. Blood Component Providers and Blood Centers Market Forecast and Analysis
9.4. ACADEMIC AND RESEARCH INSTITUTES
  9.4.1. Overview
  9.4.2. Academic and Research Institutes Market Forecast and Analysis
9.5. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  9.5.1. Overview
  9.5.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
9.6. HOSPITALS AND TRANSFUSION CENTERS
  9.6.1. Overview
  9.6.2. Hospitals and Transfusion Centers Market Forecast and Analysis
10. LEUKAPHERESIS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
  10.1.1 North America Leukapheresis Market Overview
  10.1.2 North America Leukapheresis Market Forecasts and Analysis
  10.1.3 North America Leukapheresis Market Forecasts and Analysis - By Product Type
  10.1.4 North America Leukapheresis Market Forecasts and Analysis - By Application
  10.1.5 North America Leukapheresis Market Forecasts and Analysis - By End User
  10.1.6 North America Leukapheresis Market Forecasts and Analysis - By Countries
  10.1.6.1 United States Leukapheresis Market
  10.1.6.1.1 United States Leukapheresis Market by Product Type
  10.1.6.1.2 United States Leukapheresis Market by Application
  10.1.6.1.3 United States Leukapheresis Market by End User
  10.1.6.2 Canada Leukapheresis Market
  10.1.6.2.1 Canada Leukapheresis Market by Product Type
  10.1.6.2.2 Canada Leukapheresis Market by Application
  10.1.6.2.3 Canada Leukapheresis Market by End User
  10.1.6.3 Mexico Leukapheresis Market
  10.1.6.3.1 Mexico Leukapheresis Market by Product Type
  10.1.6.3.2 Mexico Leukapheresis Market by Application
  10.1.6.3.3 Mexico Leukapheresis Market by End User
10.2. EUROPE
  10.2.1 Europe Leukapheresis Market Overview
  10.2.2 Europe Leukapheresis Market Forecasts and Analysis
  10.2.3 Europe Leukapheresis Market Forecasts and Analysis - By Product Type
  10.2.4 Europe Leukapheresis Market Forecasts and Analysis - By Application
  10.2.5 Europe Leukapheresis Market Forecasts and Analysis - By End User
  10.2.6 Europe Leukapheresis Market Forecasts and Analysis - By Countries
  10.2.6.1 Germany Leukapheresis Market
  10.2.6.1.1 Germany Leukapheresis Market by Product Type
  10.2.6.1.2 Germany Leukapheresis Market by Application
  10.2.6.1.3 Germany Leukapheresis Market by End User
  10.2.6.2 France Leukapheresis Market
  10.2.6.2.1 France Leukapheresis Market by Product Type
  10.2.6.2.2 France Leukapheresis Market by Application
  10.2.6.2.3 France Leukapheresis Market by End User
  10.2.6.3 Italy Leukapheresis Market
  10.2.6.3.1 Italy Leukapheresis Market by Product Type
  10.2.6.3.2 Italy Leukapheresis Market by Application
  10.2.6.3.3 Italy Leukapheresis Market by End User
  10.2.6.4 Spain Leukapheresis Market
  10.2.6.4.1 Spain Leukapheresis Market by Product Type
  10.2.6.4.2 Spain Leukapheresis Market by Application
  10.2.6.4.3 Spain Leukapheresis Market by End User
  10.2.6.5 United Kingdom Leukapheresis Market
  10.2.6.5.1 United Kingdom Leukapheresis Market by Product Type
  10.2.6.5.2 United Kingdom Leukapheresis Market by Application
  10.2.6.5.3 United Kingdom Leukapheresis Market by End User
10.3. ASIA-PACIFIC
  10.3.1 Asia-Pacific Leukapheresis Market Overview
  10.3.2 Asia-Pacific Leukapheresis Market Forecasts and Analysis
  10.3.3 Asia-Pacific Leukapheresis Market Forecasts and Analysis - By Product Type
  10.3.4 Asia-Pacific Leukapheresis Market Forecasts and Analysis - By Application
  10.3.5 Asia-Pacific Leukapheresis Market Forecasts and Analysis - By End User
  10.3.6 Asia-Pacific Leukapheresis Market Forecasts and Analysis - By Countries
  10.3.6.1 Australia Leukapheresis Market
  10.3.6.1.1 Australia Leukapheresis Market by Product Type
  10.3.6.1.2 Australia Leukapheresis Market by Application
  10.3.6.1.3 Australia Leukapheresis Market by End User
  10.3.6.2 China Leukapheresis Market
  10.3.6.2.1 China Leukapheresis Market by Product Type
  10.3.6.2.2 China Leukapheresis Market by Application
  10.3.6.2.3 China Leukapheresis Market by End User
  10.3.6.3 India Leukapheresis Market
  10.3.6.3.1 India Leukapheresis Market by Product Type
  10.3.6.3.2 India Leukapheresis Market by Application
  10.3.6.3.3 India Leukapheresis Market by End User
  10.3.6.4 Japan Leukapheresis Market
  10.3.6.4.1 Japan Leukapheresis Market by Product Type
  10.3.6.4.2 Japan Leukapheresis Market by Application
  10.3.6.4.3 Japan Leukapheresis Market by End User
  10.3.6.5 South Korea Leukapheresis Market
  10.3.6.5.1 South Korea Leukapheresis Market by Product Type
  10.3.6.5.2 South Korea Leukapheresis Market by Application
  10.3.6.5.3 South Korea Leukapheresis Market by End User
10.4. MIDDLE EAST AND AFRICA
  10.4.1 Middle East and Africa Leukapheresis Market Overview
  10.4.2 Middle East and Africa Leukapheresis Market Forecasts and Analysis
  10.4.3 Middle East and Africa Leukapheresis Market Forecasts and Analysis - By Product Type
  10.4.4 Middle East and Africa Leukapheresis Market Forecasts and Analysis - By Application
  10.4.5 Middle East and Africa Leukapheresis Market Forecasts and Analysis - By End User
  10.4.6 Middle East and Africa Leukapheresis Market Forecasts and Analysis - By Countries
  10.4.6.1 South Africa Leukapheresis Market
  10.4.6.1.1 South Africa Leukapheresis Market by Product Type
  10.4.6.1.2 South Africa Leukapheresis Market by Application
  10.4.6.1.3 South Africa Leukapheresis Market by End User
  10.4.6.2 Saudi Arabia Leukapheresis Market
  10.4.6.2.1 Saudi Arabia Leukapheresis Market by Product Type
  10.4.6.2.2 Saudi Arabia Leukapheresis Market by Application
  10.4.6.2.3 Saudi Arabia Leukapheresis Market by End User
  10.4.6.3 U.A.E Leukapheresis Market
  10.4.6.3.1 U.A.E Leukapheresis Market by Product Type
  10.4.6.3.2 U.A.E Leukapheresis Market by Application
  10.4.6.3.3 U.A.E Leukapheresis Market by End User
10.5. SOUTH AND CENTRAL AMERICA
  10.5.1 South and Central America Leukapheresis Market Overview
  10.5.2 South and Central America Leukapheresis Market Forecasts and Analysis
  10.5.3 South and Central America Leukapheresis Market Forecasts and Analysis - By Product Type
  10.5.4 South and Central America Leukapheresis Market Forecasts and Analysis - By Application
  10.5.5 South and Central America Leukapheresis Market Forecasts and Analysis - By End User
  10.5.6 South and Central America Leukapheresis Market Forecasts and Analysis - By Countries
  10.5.6.1 Brazil Leukapheresis Market
  10.5.6.1.1 Brazil Leukapheresis Market by Product Type
  10.5.6.1.2 Brazil Leukapheresis Market by Application
  10.5.6.1.3 Brazil Leukapheresis Market by End User
  10.5.6.2 Argentina Leukapheresis Market
  10.5.6.2.1 Argentina Leukapheresis Market by Product Type
  10.5.6.2.2 Argentina Leukapheresis Market by Application
  10.5.6.2.3 Argentina Leukapheresis Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. LEUKAPHERESIS MARKET, KEY COMPANY PROFILES
12.1. ASAHI KASEI MEDICAL
  12.1.1. Key Facts
  12.1.2. Business Description
  12.1.3. Products and Services
  12.1.4. Financial Overview
  12.1.5. SWOT Analysis
  12.1.6. Key Developments
12.2. FRESENIUS
  12.2.1. Key Facts
  12.2.2. Business Description
  12.2.3. Products and Services
  12.2.4. Financial Overview
  12.2.5. SWOT Analysis
  12.2.6. Key Developments
12.3. HAEMONETICS
  12.3.1. Key Facts
  12.3.2. Business Description
  12.3.3. Products and Services
  12.3.4. Financial Overview
  12.3.5. SWOT Analysis
  12.3.6. Key Developments
12.4. TERUMO BCT
  12.4.1. Key Facts
  12.4.2. Business Description
  12.4.3. Products and Services
  12.4.4. Financial Overview
  12.4.5. SWOT Analysis
  12.4.6. Key Developments
12.5. STEMCELL TECHNOLOGIES
  12.5.1. Key Facts
  12.5.2. Business Description
  12.5.3. Products and Services
  12.5.4. Financial Overview
  12.5.5. SWOT Analysis
  12.5.6. Key Developments
12.6. MACOPHARMA
  12.6.1. Key Facts
  12.6.2. Business Description
  12.6.3. Products and Services
  12.6.4. Financial Overview
  12.6.5. SWOT Analysis
  12.6.6. Key Developments
12.7. HEMACARE
  12.7.1. Key Facts
  12.7.2. Business Description
  12.7.3. Products and Services
  12.7.4. Financial Overview
  12.7.5. SWOT Analysis
  12.7.6. Key Developments
12.8. ALLCELLS
  12.8.1. Key Facts
  12.8.2. Business Description
  12.8.3. Products and Services
  12.8.4. Financial Overview
  12.8.5. SWOT Analysis
  12.8.6. Key Developments
12.9. STEMEXPRESS
  12.9.1. Key Facts
  12.9.2. Business Description
  12.9.3. Products and Services
  12.9.4. Financial Overview
  12.9.5. SWOT Analysis
  12.9.6. Key Developments
12.10. PPA RESEARCH GROUP
  12.10.1. Key Facts
  12.10.2. Business Description
  12.10.3. Products and Services
  12.10.4. Financial Overview
  12.10.5. SWOT Analysis
  12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT PublisherS
13.2. GLOSSARY OF TERMS
LIST OF TABLES
LIST OF FIGURES
The List of Companies
1. Asahi Kasei Medical
2. Fresenius
3. Haemonetics
4. Terumo BCT
5. STEMCELL Technologies
6. Macopharma
7. HemaCare
8. AllCells
9. StemExpress
10. PPA Research Group